Andrea Knight
- Immunology top 10%
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 8
- Immunotherapy and Immune Responses 3
-
- CAR-T cell therapy research 4
- Cancer-related Molecular Pathways 3
-
- Cytomegalovirus and herpesvirus research 4
-
- Genomics and Chromatin Dynamics 6
- RNA modifications and cancer 2
- Co-authors
- Mark W. LowdellStephen MackinnonMartin PiskáčekPaul TraversPanagiotis KottaridisSarah GraceJ. Alejandro MadrigalMartina Řezáčová
- Cited by
- ImmunologyOncologyHematology
- Partner nations
- CzechiaUnited KingdomUnited States
In The Last Decade
Andrea Knight
23 papers receiving 446 citations
Peers
Comparison fields: 5 of 58
- Immunology 277
- Oncology 133
- Hematology 53
- Epidemiology 90
- Rehabilitation 16
Countries citing papers authored by Andrea Knight
This map shows the geographic impact of Andrea Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Knight more than expected).
Fields of papers citing papers by Andrea Knight
This network shows the impact of papers produced by Andrea Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Knight. The network helps show where Andrea Knight may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrea Knight, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 3 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 3 | |
| 8 | 2021 | 9 | |
| 9 | 2020 | 10 | |
| 10 | 2019 | 9 | |
| 11 | 2018 | 7 | |
| 12 | 2017 | 15 | |
| 13 | 2016 | 48 | |
| 14 | 2015 | 17 | |
| 15 | CMV-Independent Lysis of Glioblastoma by Ex Vivo Expanded/Activated Vdelta1+ gamma-delta T Cells | 2013 | 1 |
| 16 | 2013 | 25 | |
| 17 | 2012 | 71 | |
| 18 | 2010 | 159 | |
| 19 | The role of V delta 2-negative gamma delta T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation | 2010 | 6 |
| 20 | 2005 | 24 |
About Andrea Knight
Andrea Knight is a scholar working on Immunology, Oncology and Toxicology, having authored 23 papers that have together received 451 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (8 papers), T-cell and B-cell Immunology (8 papers), Genomics and Chromatin Dynamics (6 papers), CAR-T cell therapy research (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Immunotherapy and Immune Responses (3 papers), Cancer-related Molecular Pathways (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (277 citations), Oncology (133 citations) and Hematology (53 citations). Andrea Knight has collaborated with scholars based in Czechia, United Kingdom and United States. Frequent co-authors include Mark W. Lowdell, Stephen Mackinnon, Martin Piskáček, Paul Travers, Panagiotis Kottaridis, Sarah Grace, J. Alejandro Madrigal, Martina Řezáčová, Roman Hájek and Michael Gleeson. Their work appears in journals such as Blood, The Journal of Immunology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.